PEA works through the "entourage effect" of the endocannabinoid system without directly binding CB1/CB2 receptors. Its primary mechanism: (1) PPAR-α nuclear receptor activation — turning on anti-inflammatory gene transcription; (2) inhibition of FAAH enzyme — which slows the breakdown of anandamide (your body's natural cannabinoid), indirectly boosting endocannabinoid tone; (3) mast cell stabilization — preventing degranulation and histamine release; (4) glial cell modulation — reducing neuroinflammation by calming overactivated microglia and astrocytes. The pain-relieving effect is distinct from NSAIDs (no COX inhibition) and opioids (no mu-receptor binding), making it safe to combine with both.
No critical interactions identified.
Independently graded against 173,636 indexed supplements with 177 published clinical interactions, sourced from PubMed, FDA CAERS, openFDA, and NIH DSLD | Last updated:
Not medical advice. Based on published clinical research and systematic reviews.